Vanta Bioscience signs Rs 29 crores deal with Emcure Pharmaceuticals
To provide services through its step-down subsidiary ‘Vayam Research Solutions’
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Zydus Cadila gets US FDA nod to market generic anti-epileptic tablets
The drug will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad
Evonik Catalysts expands production of activated metal catalysts in India
The new state-of-the-art production facility allows Evonik to fully utilise its capacities in Dombivli while establishing…
Syngene International, BIRAC set up CAPS
The collaboration is part of National Biopharma Mission
Syngene International announced the opening of its Centre for Advanced…
Sun Pharma launches ready-to-infuse INFUGEM in the US
INFUGEM (gemcitabine in sodium chloride injection) is the first and only chemotherapy product in a premixed, ready-to-infuse…
Purdue’s Sackler family fights ‘inflammatory’ Massachusetts opioid case
The case is among roughly 2,000 lawsuits filed mostly by state and local governments seeking to hold Purdue and other…
Japan’s Takeda invites Brazilian pharmaceutical firms to bid for Latam business: Sources
Takeda expects to fetch more than $1 billion for the Latin American operations. In Brazil, Takeda owns popular over the counter…
Servier joins Access Accelerated to fight against non-communicable diseases
Now consisting of 26 pharmaceutical companies, Access Accelerated unites industry action and applies member companies' global…
Lupin’s Pithampur Unit-3 (Indore) receives EIR from USFDA
Lupin’s Pithampur Unit-3 is involved in the manufacture of Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs) and Topical…
Exports in March to reach $32.38 billion: Suresh Prabhu
Exports will cross the $331-billion mark in the year 2018-19, Commerce and Industry Minister said
Aurobindo Pharma, Lupin recall drugs in US market
The USFDA has classified the action for Aurobindo Pharma as a Class II recall, and for Lupin, the health regulator classified the…
Biocon to soon expand its presence in biosimilars in US market
Dr Mazumdar Shaw, CMD, Biocon said that women must be encouraged to become entrepreneurs
Emcure launches generic Eribulin for treatment of metastatic breast cancer
The drug will be available in India at approximately 40 per cent cost of the innovator brand
Thermo Fisher Scientific partners with FSSAI
Opens advanced food safety solution centre at Ghaziabad, UP
Lupin Bioresearch Centre completes fifth successful US FDA inspection
The inspection also included review of studies done at the center’s new site at Lupin Research Park, Pune
IPA appoints Sudarshan Jain as Secretary General
Having 40 years of experience in healthcare sector, Jain has worked with top Indian and multinational companies
Strides to launch Potassium Chloride Extended-Release tablets in the US market
Product jointly developed with Pharmaceutics International, Inc to be commercialized by Strides in the US market
2nd India SCM Leadership Summit to be held on May 16
The purpose of this summit is to meet the entire vale chain within supply chain planning, execution and management in one room at…
CPhI Japan sees Japanese R&D reinvigorated with international partnerships proliferating
Japan’s largest pharma trade event played host to almost 20,000 pharma professionals alongside 571 exhibitors from 29 countries,…
Lupin launches Fluocinonide Ointment USP 0.05 per cent
Lupin’s Fluocinonide Ointment USP, 0.0 per cent, is the generic version of County Line Pharmaceuticals LLC’s Lidex Ointment 0.05…